Clinical trial
Double-blind Placebo Controlled Trial Using Pentoxifylline Associated With Pentavalent Antimony in Cutaneous Leishmaniasis
NCT01381055 is registered in ClinicalTrials.gov with Paulo Roberto Lima Machado as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-blind Placebo Controlled Trial Using Pentoxifylline Associated With Pentavalent Antimony in Cutaneous Leishmaniasis
- Lead sponsor
- Paulo Roberto Lima Machado
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- March 31, 2012
- Completion date
- October 31, 2015
- Enrollment
- 164 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
cutaneous leishmaniasis